Literature DB >> 32039916

Chikungunya infection: de-linking replication from symptomatology reveals the central role of muscle.

Anne Moscona.   

Abstract

Chikungunya virus (CHIKV) is an emerging arbovirus, endemic in many parts of the world, that is spread by travelers and adapts to new mosquito vectors that live in temperate climates. CHIKV replicates in many host tissues and initially causes a self-limiting febrile illness similar to dengue. However, in 30%-40% of cases, CHIKV also causes long-term painful and debilitating muscle and joint pain, the pathogenesis of which remains unknown. In this issue of the JCI, Lentscher et al. engineered a skeletal muscle-restricted CHIKV to show that while musculoskeletal disease requires viral replication in affected muscle, muscular pathology is mediated by host immunological factors. These findings de-link viral replication and disease symptoms, illuminate the virus-host interplay in CHIKV symptomatology, and raise the possibility that immune modulation is a therapeutic option. The results also highlight possible solutions to existing vaccine barriers and provide insights that may apply to other viral diseases.

Entities:  

Mesh:

Year:  2020        PMID: 32039916      PMCID: PMC7269576          DOI: 10.1172/JCI134746

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

Review 1.  Interspecies transmission and chikungunya virus emergence.

Authors:  Konstantin A Tsetsarkin; Rubing Chen; Scott C Weaver
Journal:  Curr Opin Virol       Date:  2016-03-14       Impact factor: 7.090

Review 2.  Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies.

Authors:  Laurie A Silva; Terence S Dermody
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

3.  Attenuation of Chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein.

Authors:  Rodion Gorchakov; Eryu Wang; Grace Leal; Naomi L Forrester; Kenneth Plante; Shannan L Rossi; Charalambos D Partidos; A Paige Adams; Robert L Seymour; James Weger; Erin M Borland; Michael B Sherman; Ann M Powers; Jorge E Osorio; Scott C Weaver
Journal:  J Virol       Date:  2012-03-28       Impact factor: 5.103

4.  Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial.

Authors:  Lee-Jah Chang; Kimberly A Dowd; Floreliz H Mendoza; Jamie G Saunders; Sandra Sitar; Sarah H Plummer; Galina Yamshchikov; Uzma N Sarwar; Zonghui Hu; Mary E Enama; Robert T Bailer; Richard A Koup; Richard M Schwartz; Wataru Akahata; Gary J Nabel; John R Mascola; Theodore C Pierson; Barney S Graham; Julie E Ledgerwood
Journal:  Lancet       Date:  2014-08-14       Impact factor: 79.321

5.  Chikungunya fever in the United States: a fifteen year review of cases.

Authors:  Katherine B Gibney; Marc Fischer; Harry E Prince; Laura D Kramer; Kirsten St George; Olga L Kosoy; Janeen J Laven; J Erin Staples
Journal:  Clin Infect Dis       Date:  2011-01-17       Impact factor: 9.079

6.  Chikungunya virus replication in skeletal muscle cells is required for disease development.

Authors:  Anthony J Lentscher; Mary K McCarthy; Nicholas A May; Bennett J Davenport; Stephanie A Montgomery; Krishnan Raghunathan; Nicole McAllister; Laurie A Silva; Thomas E Morrison; Terence S Dermody
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

Review 7.  Arthritogenic alphaviruses--an overview.

Authors:  Andreas Suhrbier; Marie-Christine Jaffar-Bandjee; Philippe Gasque
Journal:  Nat Rev Rheumatol       Date:  2012-05-08       Impact factor: 20.543

8.  A mammalian microRNA expression atlas based on small RNA library sequencing.

Authors:  Pablo Landgraf; Mirabela Rusu; Robert Sheridan; Alain Sewer; Nicola Iovino; Alexei Aravin; Sébastien Pfeffer; Amanda Rice; Alice O Kamphorst; Markus Landthaler; Carolina Lin; Nicholas D Socci; Leandro Hermida; Valerio Fulci; Sabina Chiaretti; Robin Foà; Julia Schliwka; Uta Fuchs; Astrid Novosel; Roman-Ulrich Müller; Bernhard Schermer; Ute Bissels; Jason Inman; Quang Phan; Minchen Chien; David B Weir; Ruchi Choksi; Gabriella De Vita; Daniela Frezzetti; Hans-Ingo Trompeter; Veit Hornung; Grace Teng; Gunther Hartmann; Miklos Palkovits; Roberto Di Lauro; Peter Wernet; Giuseppe Macino; Charles E Rogler; James W Nagle; Jingyue Ju; F Nina Papavasiliou; Thomas Benzing; Peter Lichter; Wayne Tam; Michael J Brownstein; Andreas Bosio; Arndt Borkhardt; James J Russo; Chris Sander; Mihaela Zavolan; Thomas Tuschl
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

9.  The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus.

Authors:  Moritz U G Kraemer; Marianne E Sinka; Kirsten A Duda; Adrian Q N Mylne; Freya M Shearer; Christopher M Barker; Chester G Moore; Roberta G Carvalho; Giovanini E Coelho; Wim Van Bortel; Guy Hendrickx; Francis Schaffner; Iqbal R F Elyazar; Hwa-Jen Teng; Oliver J Brady; Jane P Messina; David M Pigott; Thomas W Scott; David L Smith; G R William Wint; Nick Golding; Simon I Hay
Journal:  Elife       Date:  2015-06-30       Impact factor: 8.140

10.  Multi-peaked adaptive landscape for chikungunya virus evolution predicts continued fitness optimization in Aedes albopictus mosquitoes.

Authors:  Konstantin A Tsetsarkin; Rubing Chen; Ruimei Yun; Shannan L Rossi; Kenneth S Plante; Mathilde Guerbois; Naomi Forrester; Guey Chuen Perng; Easwaran Sreekumar; Grace Leal; Jing Huang; Suchetana Mukhopadhyay; Scott C Weaver
Journal:  Nat Commun       Date:  2014-06-16       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.